| MolName | 2-[(E)-[amino-(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino]oxy-N-benzylacetamide |
| MolecularFormula | C12H14N6O3 |
| Smiles | N/C(/c1nonc1N)=N/OCC(NCc1ccccc1)=O |
| InChI | InChI=1S/C12H14N6O3/c13-11(10-12(14)18-21-16-10)17-20-7-9(19)15-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H2,13,17)(H2,14,18)(H,15,19) |
| InChIK | MZSNMBREPSFVDI-UHFFFAOYSA-N |
| TotalMolweight | 290.282 |
| Molweight | 290.282 |
| MonoisotopicMass | 290.112739 |
| CLogP | 0.3128 |
| CLogS | -2.042 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 226.97 |
| Relative PSA | 0.4961 |
| PolarSurfaceArea | 141.65 |
| Druglikeness | 3.1877 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.66667 |
| Fragments | 1 |
| Non HAtoms | 21 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 6 |
| Rings Closures | 2 |
| Small Rings | 2 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 3 |
| Symmetricatoms | 2 |
| Amides | 1 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - 2-[(E)-[amino-(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino]oxy-N-benzylacetamide | 2 - 2-[(E)-[amino-(4-amino-1,2,5-oxadiazol-3-yl)methylidene]amino]oxy-N-benzylacetamide